Factors Associated with Post-Seasonal Serological Titer and Risk Factors for Infection with the Pandemic A/H1N1 Virus in the French General Population
暂无分享,去创建一个
Simon Cauchemez | Antoine Flahault | Fabrice Carrat | Pierre-Yves Boëlle | Nathanael Lapidus | Michaël Schwarzinger | Michel Setbon | Nicolas Salez | Laurent Abel | Pierre Le Cann | A. Flahault | S. Cauchemez | F. Carrat | P. Böelle | M. Setbon | L. Abel | F. Vély | É. Vivier | N. Lapidus | Nanikaly Moyen | L. Andréoletti | N. Salez | Xavier de Lamballerie | M. Gougeon | M. Schwarzinger | R. Delabre | Marianne Leruez-Ville | M. Leruez-Ville | P. le Cann | Marie-Lise Gougeon | Pascal Ferrari | Laurent Andreoletti | Rosemary M. Delabre | Nanikaly Moyen | Frédéric Vely | Éric Vivier | Michèle Legeas | X. D. de Lamballerie | M. Legeas | P. Ferrari | F. Vely | R. M. Delabre
[1] Jeffrey Shaman,et al. Absolute humidity modulates influenza survival, transmission, and seasonality , 2009, Proceedings of the National Academy of Sciences.
[2] Alberto Arnedo-Pena,et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. , 2010, Vaccine.
[3] Weizhong Yang,et al. The Seroprevalence of Pandemic Influenza H1N1 (2009) Virus in China , 2011, PLoS ONE.
[4] A. Berger,et al. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? , 2010, Medical Microbiology and Immunology.
[5] Benjamin J Cowling,et al. Household Transmission of 2009 Pandemic Influenza A (H1N1): A Systematic Review and Meta-analysis , 2012, Epidemiology.
[6] A. Flahault,et al. Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort , 2012, BMC Public Health.
[7] R. Charrel,et al. Novel Virus Influenza A (H1N1sw) in South-Eastern France, April-August 2009 , 2010, PloS one.
[8] Mark S. Handcock,et al. Estimating Within-School Contact Networks to Understand Influenza Transmission , 2011, The annals of applied statistics.
[9] Libo Dong,et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.
[10] L. Rosella,et al. Seroprevalence of Pandemic Influenza H1N1 in Ontario from January 2009–May 2010 , 2011, PloS one.
[11] N. Andrews,et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study , 2010, The Lancet.
[12] Thomas Lumley,et al. Complex Surveys: A Guide to Analysis Using R , 2010 .
[13] David L MacIntosh,et al. Modeling the airborne survival of influenza virus in a residential setting: the impacts of home humidification , 2010, Environmental health : a global access science source.
[14] A. Valleron,et al. Causes of early-onset type 1 diabetes: toward data-driven environmental approaches , 2008, The Journal of experimental medicine.
[15] Benjamin J Cowling,et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] F. Carrat,et al. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[17] F. Polack,et al. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes , 2010, Nature Medicine.
[18] M. Hernandez,et al. Airway protease/antiprotease imbalance in atopic asthmatics contributes to increased Influenza A virus cleavage and replication , 2012, Respiratory Research.
[19] M. Stämpfli,et al. Cigarette smoke attenuation of poly I:C-induced innate antiviral responses in human PBMC is mainly due to inhibition of IFN-beta production. , 2009, Molecular immunology.
[20] Bonita E. Lee,et al. Transmission of pandemic influenza A (H1N1) 2009 within households: Edmonton, Canada. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[21] Z. Vajo,et al. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009–10 influenza season: a multicentre, randomised controlled trial , 2010, The Lancet.
[22] David E. Booth,et al. Analysis of Incomplete Multivariate Data , 2000, Technometrics.
[23] H. Kelly,et al. Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. , 2011, Vaccine.
[24] P. Holt,et al. The effect of cigarette smoking on susceptibility to epidemic influenza and on serological responses to live attenuated and killed subunit influenza vaccines , 1976, Journal of Hygiene.
[25] F. Carrat,et al. Planning for the next influenza H1N1 season: a modelling study , 2010, BMC infectious diseases.
[26] Q. S. Huang,et al. Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic , 2010, PloS one.
[27] F. Dawood,et al. Household Transmission of Pandemic (H1N1) 2009, San Antonio, Texas, USA, April–May 2009 , 2010, Emerging infectious diseases.
[28] Y. Juhn. Influence of Asthma Epidemiology on the Risk for Other Diseases , 2012, Allergy, asthma & immunology research.
[29] Wai-ming Lee,et al. Increased H1N1 infection rate in children with asthma. , 2012, American journal of respiratory and critical care medicine.
[30] H. Seale,et al. Serological survey of 2009 H1N1 influenza in residents of Beijing, China , 2010, Epidemiology and Infection.
[31] J. Kark,et al. Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men. , 1982, The New England journal of medicine.
[32] Wei Zhang,et al. Cigarette smoke extract suppresses the RIG-I-initiated innate immune response to influenza virus in the human lung. , 2011, American journal of physiology. Lung cellular and molecular physiology.
[33] M. Cretikos,et al. Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere Winter , 2010, PloS one.
[34] Y. Hsieh,et al. Factors associated with infection by 2009 pandemic H1N1 influenza virus during different phases of the epidemic. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[35] M. Stämpfli,et al. Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke , 2008, Journal of leukocyte biology.
[36] Atul J. Butte,et al. An Environment-Wide Association Study (EWAS) on Type 2 Diabetes Mellitus , 2010, PloS one.
[37] David N. Reshef,et al. Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009 , 2010, BMC infectious diseases.
[38] W. Carman,et al. Rapid communications Influenza A ( H 1 N 1 ) 2009 antibody seroprevalence in Scotland following the 2010 / 11 influenza season , 2011 .
[39] J. Nauta,et al. Eliminating bias in the estimation of the geometric mean of HI titres. , 2006, Biologicals : journal of the International Association of Biological Standardization.
[40] P. Diggle,et al. Modelling multivariate binary data with alternating logistic regressions , 1993 .
[41] N. Ferguson,et al. Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza , 2011, Proceedings of the National Academy of Sciences.
[42] D. Siev. Reply to "Nauta JJP, Eliminating bias in the estimation of the geometric mean of HI titers" [Biologicals 2006;34(3):183-6]. , 2007, Biologicals : journal of the International Association of Biological Standardization.
[43] Laura C. Rosella,et al. Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada , 2010, PLoS medicine.
[44] Kui-biao Li,et al. Antibody Dynamics of 2009 Influenza A (H1N1) Virus in Infected Patients and Vaccinated People in China , 2011, PloS one.
[45] J. Wood,et al. Comparison of influenza serological techniques by international collaborative study. , 1994, Vaccine.
[46] N. Benowitz,et al. Cigarette smoking and infection. , 2004, Archives of internal medicine.
[47] Anthony W. Mounts,et al. Estimating age‐specific cumulative incidence for the 2009 influenza pandemic: a meta‐analysis of A(H1N1)pdm09 serological studies from 19 countries , 2013, Influenza and other respiratory viruses.
[48] Xinzhang,et al. Serologic survey of pandemic influenza A (H1N1 2009) in Beijing, China. , 2011, Preventive medicine.
[49] Eduardo Lazcano-Ponce,et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City , 2009, BMJ : British Medical Journal.
[50] Michel Roger,et al. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] Brendan Giles,et al. Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza , 2010, PLoS currents.
[52] Shweta Bansal,et al. The Shifting Demographic Landscape of Pandemic Influenza , 2010, PloS one.
[53] A. Cook,et al. 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. , 2010, JAMA.
[54] S. Iamsirithaworn,et al. Serological Response to the 2009 Pandemic Influenza A (H1N1) Virus for Disease Diagnosis and Estimating the Infection Rate in Thai Population , 2011, PloS one.
[55] John D. Storey,et al. Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach , 2004 .
[56] Santosh S. Koratkar,et al. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India , 2010, BMC infectious diseases.
[57] Richard K. Zimmerman,et al. Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USA , 2010, PloS one.
[58] P. Simmonds,et al. Sero-Prevalence and Incidence of A/H1N1 2009 Influenza Infection in Scotland in Winter 2009–2010 , 2011, PloS one.
[59] R. Pebody,et al. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. , 2011, Vaccine.
[60] Kee Seng Chia,et al. Risk Factors for Pandemic (H1N1) 2009 Seroconversion among Adults, Singapore, 2009 , 2011, Emerging infectious diseases.
[61] B. Cowling,et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. , 2010, Clinical Infectious Diseases.
[62] A. Flahault,et al. Pandemic Influenza Due to pH1N1/2009 Virus: Estimation of Infection Burden in Reunion Island through a Prospective Serosurvey, Austral Winter 2009 , 2011, PloS one.
[63] D. Skowronski,et al. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic , 2010, Canadian Medical Association Journal.
[64] P. Wark,et al. Innate immunity to influenza in chronic airways diseases , 2012, Respirology.
[65] D B Rubin,et al. Multiple imputation in health-care databases: an overview and some applications. , 1991, Statistics in medicine.
[66] I. Jaspers,et al. Epithelial cells from smokers modify dendritic cell responses in the context of influenza infection. , 2011, American journal of respiratory cell and molecular biology.
[67] A. Flahault,et al. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[68] W. Carman,et al. Influenza A(H1N1)2009 antibody seroprevalence in Scotland following the 2010/11 influenza season. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[69] Jin-Won Chung,et al. Risk factors for laboratory-confirmed household transmission of pandemic H1N1 2009 infection. , 2010, American journal of infection control.